raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:217616

Fatty acid oxidation and ketogenesis disorder with dilated cardiomyopathy

Type
Category
Group
Group of disorders
Status
active

This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enFatty acid oxidation and ketogenesis disorder with dilated cardiomyopathy
frAnomalie de l'oxydation des acides gras et de la cétogenèse avec cardiomyopathie dilatée
deFettsäureoxidationsstörung und Ketogenese-Defekt mit dilatativer Kardiomyopathie
esTrastorno de la cetogénesis y de la oxidación de los ácidos grasos con miocardiopatía dilatada
itDifetto dell'ossidazione degli acidi grassi e della chetogenesi con cardiomiopatia dilatativa
nlVetzuuroxidatie- en ketogenesestoornis met gedilateerde cardiomyopathie
ptDoença da oxidação dos ácidos gordos e cetogénese com miocardiopatia dilatada
plZaburzenie oksydacji kwasów tłuszczowych i ketogenezy z kardiomiopatią rozstrzeniową
csDilatační kardiomyopatie s poruchou oxidace mastných kyselin a ketogenezí
ukПорушення окислення жирних кислот та кетогенезу з дилатаційною кардіоміопатією
zh脂肪酸氧化和生酮障碍伴扩张型心肌病
trDilate kardiyomiyopatili yağ asidi oksidasyonu ve ketogenez bozukluğu
2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
MONDO16336Evalidated
UMLSC5680875Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

Children (2):

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

0 records

No prevalence record in this release.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card